Dr. Gootenberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6915 Breezewood Ter
Rockville, MD 20852Phone+1 301-881-0818Fax+1 301-881-0819
Education & Training
- National Capital ConsortiumFellowship, Pediatric Hematology/Oncology, 1978 - 1981
- Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 1975 - 1978
- Albert Einstein College of MedicineClass of 1975, MD, AOA
- Harvard UniversityAB, Biochemical Sciences, Mgna cum Laude, 1967 - 1971
Certifications & Licensure
- MD State Medical License 1981 - 2026
- VA State Medical License 1987 - 2014
- DC State Medical License 1981 - 2013
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- 60 citationsU.S. Food and Drug Administration Approval: Peginterferon-alfa-2b for the Adjuvant Treatment of Patients with MelanomaThomas M. Herndon, Suzanne Demko, Xiaoping Jiang, Kun He, Joseph E. Gootenberg
The Oncologist. 2012-10-01 - 34 citationsEribulin Mesylate for the Treatment of Patients with Refractory Metastatic Breast Cancer: Use of a “Physician's Choice” Control Arm in a Randomized Approval TrialMartha Donoghue, Steven Lemery, Weishi Yuan, Kun He, Rajeshwari Sridhara
Clinical Cancer Research. 2012-03-15 - 69 citationsU.S. Food and Drug Administration Approval: Ofatumumab for the Treatment of Patients with Chronic Lymphocytic Leukemia Refractory to Fludarabine and AlemtuzumabSteven Lemery, Jenny Zhang Zhang, Mark D. Rothmann, Jun Yang, Justin C. Earp
Clinical Cancer Research. 2010-09-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: